Latest News from WA Gulf
Belfast Telegraph
9 minutes ago
- General
- Belfast Telegraph
Four killed in South Korean navy patrol plane crash
The P-3 patrol plane took off from its base in the city of Pohang at 1.43pm and crashed due to unknown reasons, the navy said in a statement. It said it had identified the bodies of the four crew members and was in the process of recovering them. There were no immediate reports of civilian casualties on the ground. The navy set up a task force to investigate the crash and temporarily grounded its P-3s. An emergency office in Pohang said that rescuers and fire trucks were dispatched to the site after receiving reports from residents that an aircraft crashed on a hill near a block of flats and caused a fire. Photos showed firefighters and emergency vehicles near the crash site with flames as smoke engulfed trees. Fire crews sprayed water on what appeared to be the aircraft debris. In December, a Jeju Air passenger plane crashed at Muan International Airport in southern South Korea, killing all but two of the 181 people on board.
Belfast Telegraph
9 minutes ago
- Climate
- Belfast Telegraph
Man missing after glacier in Switzerland collapses and destroys village
The landslide sent plumes of dust into the sky and coated with mud nearly all of an Alpine village that authorities had evacuated earlier this month as a precaution. State councilor Stephane Ganzer told Radio Television Suisse that 90% of the village was destroyed. The Cantonal Police of Valais said that a search and rescue operation was under way for the man, whose name has not been made public, and it involved a drone with a thermal camera. The regional government said in a statement that a large chunk of the Birch Glacier above the village had broken off, causing the landslide, which also buried the nearby Lonza River bed, raising the possibility of dammed water flows. Video on social media and Swiss television showed that the mudslide near Blatten, in the southern Lotschental valley, partially submerged homes and other buildings under a mass of sludge. In recent days, authorities had ordered the evacuation of about 300 people, as well as all livestock, from the village amid fears that the 52 million-cubic foot glacier was at risk of collapse. Swiss glaciologists have repeatedly expressed concerns about a thaw in recent years – attributed in large part to climate change – that has accelerated the retreat of glaciers in Switzerland. The landlocked Alpine country has the most glaciers of any country in Europe, and saw 4% of its total glacier volume disappear in 2023. That was the second-biggest decline in a single year after a 6% drop in 2022.
The Star
9 minutes ago
- Business
- The Star
Philippine durian gains market access to Egypt
MANILA: (Bernama-Xinhua) The Philippine durian has gained market access to Egypt, the Department of Agriculture's Bureau of Plant Industry said, Xinhua reported. "This development, confirmed on May 18, 2025, marks the successful conclusion of nearly two years of technical negotiations, pest risk assessments, and regulatory cooperation between the Philippines and Egypt," the bureau said in a statement on social media on Wednesday (May 28) afternoon. According to the bureau, the fresh market access reflects regulatory compliance and growing confidence in the country's plant health and safety systems. The path to market access began in June 2023, when the Philippines formally notified its intent to export fresh durian to Egypt. Since then, the bureau said it has actively collaborated with Egypt's Central Administration for Plant Quarantine, addressing key concerns related to pest surveillance, phytosanitary measures, and export protocols. According to the bureau, the Philippines exported 14,156.87 metric tonnes of fresh durian in 2024 to various international destinations, representing a 199.23 per cent increase from 2023, which highlights the growing global demand for Philippine durian. - Bernama-Xinhua
Yahoo
9 minutes ago
- Business
- Yahoo
CraniUS Therapeutics Awarded Maryland Tech Council's "2025 Emerging Life Sciences Company of the Year"
BALTIMORE, May 29, 2025 /PRNewswire/ -- CraniUS Therapeutics, a cutting-edge medical device company advancing intracranial drug delivery, is proud to announce it has been voted the "2025 Emerging Life Sciences Company of the Year" by the Maryland Tech Council (MTC). The honor was presented during the Council's prestigious Industry Awards Celebration, which drew over 600 attendees, and recognizes the state's most innovative and impactful companies in technology and life sciences. The company's Founder and Executive Chairman, Dr. Chad Gordon, is a leader in Neuroplastic and Reconstructive Surgery. He serves as Section Chief and Fellowship Program Director at Johns Hopkins School of Medicine. Over his career, Dr. Gordon has secured 21 patents, led three successful venture exits, and conducted three first-in-human studies evaluating advanced cranial implants. His invention of the NeuroPASS™ device—CraniUS's core innovation—sparked the company's formation. This award acknowledges CraniUS's leadership and its groundbreaking development of the NeuroPASS™ platform, which enables direct, reliable delivery of therapeutics to the brain—addressing one of the most persistent challenges in treating brain tumors and other neurological conditions. "We are honored to be recognized by the Maryland Tech Council with this year's Emerging Company Award," said Dr. Gordon. "This milestone reflects not only the dedication of our entire team but also the urgent need for transformative solutions in neurotherapeutics. We are extremely proud to be pioneering the new field of functional neurocranial implants inspired by Neuroplastic Surgery and driving this critical work forward—from right here in Maryland." Mike Maglin, CEO of CraniUS Therapeutics, added, "This award is a testament to the meaningful progress we've made and the momentum we've built—spanning scientific innovation, strategic alliances, and investor engagement. We remain committed to redefining how patients with neurological diseases receive life-changing medicines." The Industry Awards Celebration is Maryland's premier event honoring excellence in technology, life sciences, and innovation. CraniUS was selected from a competitive field of nominees for its rapid growth, strong leadership, and the promise of its revolutionary device platform—employing patented neurotechnology—designed to reshape treatment approaches for conditions such as neurodegenerative diseases, movement disorders, and aggressive brain cancers. About CraniUS TherapeuticsCraniUS Therapeutics is a neurotechnology company developing the first fully implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery. Its flagship device, NeuroPASS™, is designed to transform the treatment landscape for debilitating neurological conditions across multiple disease types. CraniUS Therapeutics is headquartered in Baltimore, Maryland, and collaborates globally with industry leading experts in neurosurgery, drug delivery, implant design, device engineering, and manufacturing. Media Contact:Elizabeth A. Dale, EdDExecutive Advisor, CraniUS Therapeuticsedale@ View original content to download multimedia: SOURCE CraniUS Therapeutics Melden Sie sich an, um Ihr Portfolio aufzurufen.
Yahoo
9 minutes ago
- Business
- Yahoo
Statutory Earnings May Not Be The Best Way To Understand Zedcor's (CVE:ZDC) True Position
Zedcor Inc. (CVE:ZDC) recently released a strong earnings report, and the market responded by raising the share price. However, we think that shareholders should be aware of some other factors beyond the profit numbers. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. This ratio tells us how much of a company's profit is not backed by free cashflow. Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth. Zedcor has an accrual ratio of 0.48 for the year to March 2025. As a general rule, that bodes poorly for future profitability. And indeed, during the period the company didn't produce any free cash flow whatsoever. Even though it reported a profit of CA$2.72m, a look at free cash flow indicates it actually burnt through CA$18m in the last year. We also note that Zedcor's free cash flow was actually negative last year as well, so we could understand if shareholders were bothered by its outflow of CA$18m. Having said that, there is more to consider. We can look at how unusual items in the profit and loss statement impacted its accrual ratio, as well as explore how dilution is impacting shareholders negatively. View our latest analysis for Zedcor That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. To understand the value of a company's earnings growth, it is imperative to consider any dilution of shareholders' interests. As it happens, Zedcor issued 12% more new shares over the last year. As a result, its net income is now split between a greater number of shares. To talk about net income, without noticing earnings per share, is to be distracted by the big numbers while ignoring the smaller numbers that talk to per share value. Check out Zedcor's historical EPS growth by clicking on this link. Three years ago, Zedcor lost money. The good news is that profit was up 90% in the last twelve months. But EPS was less impressive, up only 50% in that time. So you can see that the dilution has had a bit of an impact on shareholders. In the long term, earnings per share growth should beget share price growth. So it will certainly be a positive for shareholders if Zedcor can grow EPS persistently. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For the ordinary retail shareholder, EPS is a great measure to check your hypothetical "share" of the company's profit. The fact that the company had unusual items boosting profit by CA$466k, in the last year, probably goes some way to explain why its accrual ratio was so weak. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. If Zedcor doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year. Zedcor didn't back up its earnings with free cashflow, but this isn't too surprising given profits were inflated by unusual items. The dilution means the results are weaker when viewed from a per-share perspective. On reflection, the above-mentioned factors give us the strong impression that Zedcor'sunderlying earnings power is not as good as it might seem, based on the statutory profit numbers. If you want to do dive deeper into Zedcor, you'd also look into what risks it is currently facing. You'd be interested to know, that we found 1 warning sign for Zedcor and you'll want to know about this. In this article we've looked at a number of factors that can impair the utility of profit numbers, and we've come away cautious. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
